Modified cells of the immune system can be used for the treatment of complex and severe diseases, such as oncology, autoimmune, neurodegenerative diseases. The list of FDA-approved medical practices that use cells from a patient’s immune system is growing every day.

These severe diseases are currently the leading causes of death in the global society and are almost inevitable with age.


We offer to save your young and healthy cells to create personalized medicines on their basis, if that becomes necessary in the future. If you are interested in the information published on our website, be sure to consult your doctor.

If you are interested in the emerging personalized medicine approaches, want to use advanced therapeutic methods in your practice, or already practice treatment using cells of the immune system, we invite you to cooperate with us!

We offer various opportunities for cooperation: upon request we can store your patients' cells in the OnniBiotech cryobank as well as provide ready-made cells for treatment to your clinics.

With your help, the cryobank of cells being created today in Finland will become a network of European cryobanks tomorrow.
Contact us for a further discussion.

ONNI Biotech offers:

1. Original X-somes for stimulation, activation and expansion of human immune cells as well as routine preparators for every day cell culture work and analysis.
2. Cell therapy services and cell bank manufacturing.
3. Molecular cloning services.
4. Expression in mammalian cell culture and purification of recombinant proteins.

Today, the research and techniques for the use of cells of the immune system in the treatment of severe diseases is developing rapidly. In 2022, 20 years have passed since the first cancer treatment using CAR-T therapy. In 2023 this technology is already being used all around the world.

The average price of CAR-T cell therapy is $ 375,000, the minimum price is $ 90,000 (China), and the maximum price is EUR 848,417 (Germany).
The methods being developed now use the most recent patient cells, that is, cells already weakened by the disease. We offer to freeze and preserve the younger, healthier cells. Because of this, the quality of therapy will increase significantly. Due to the smaller number of injected cells, the cost of the procedure will also fall.

If you are considering investing in a cutting-edge, rewarding and medicine-oriented project, the creation of a cryobank of immune cells is certainly, an excellent choice.